Speaker Profile
M.D., Ph.D., MRCP, Professor, UCSF
Biography
Dr. Minnie M. Sarwal is an adult and pediatric trained transplant nephrologist who heads the kidney pancreas transplant program at UCSF for transplantation of patients with Type 1 Diabetes and renal failure. She has spearheaded new diagnostics for precision medicine to personalize diagnosis of transplant rejection. Her lab has been consecutively funded by the NIH for 30 yrs and leads in computational drug repuprosing and population scale EHR analysis to improve outcomes for chronic disease.
Sarwal is trained in India and the UK, competing her MD in India and advanced cliical training at Guys Hospital, London and Addenbrooke's Hospital in Cambridge. She earned her doctorate in molecular genetics at the University of Cambridge under her mentor Nobel Laureate Sydney Brenner.
Sarwal is an exited enterpreneur from Stanford and continues to do pivotal work to produce commercially available tests and new compunds for organ transplant rejection and chronic mutli-organ disease
Session Abstract – PMWC 2027 Silicon Valley
Track Chair:
Christina Curtis, Stanford
PMWC Award Ceremony
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio (Luminary)
• Alexandre Loupy, Inserm / Paris Transplant Group (Pioneer)
Featured Speakers
• Joe DeRisi, UCSF / CZ Biohub / Delve Bio
• Alexandre Loupy, Inserm / Paris Transplant Group
• Minnie Sarwal, UCSF
• Kiran Khush, Stanford
• Iwijn De Vlaminck, Cornell
• Maarten Naesens, KU Leuven
• Charles Chiu, UCSF
• Michael Snyder, Stanford
• Duncan MacCannell, CDC
• Chaz Langelier, UCSF
• Yoel Sadovsky, Stanford
• Ananth Karumanchi, Cedars-Sinai
• Gabriel Bien-Willner, Palmetto GBA / MolDX
• Dawn Cardeiro, Roche Diagnostics
• Bruce Quinn, Bruce Quinn Associates
Transplant & Organ Health Diagnostics
From biopsy to blood-based monitoring of rejection, injury, and infection.
Blood-Based Omics and Host Response in Infection
Metagenomics and host-response signals for difficult infectious disease cases.
Maternal & Fetal Health
From prenatal screening to actionable maternal and placental biomarkers.
From Signal to Standard of Care
What makes a non-cancer blood test clinically actionable and reimbursable.
PMWC Hall of Impact
Previous Speakers Include
Nobel laureates, technology founders, regulators, CEOs and scientific pioneers who have taken the PMWC stage.
